The six regional events comprising the first Pitch@Palace Canada On Tour series are now complete. The tour concluded on May 7 in Montreal, at the McIntyre Medical Sciences Building on the McGill University campus.
Of the 18 entrepreneurs from Quebec who pitched their businesses, the following four made it through to the next round:
- iinjec Technologies has created an easy-to-use Safety Syringe that addresses supply shortages in mass global vaccination campaigns, while reducing unintended injuries, contamination, dosing errors, and disposal challenges.
- NERv Technology is developing a smart catheter with embedded micro-sensors to detect gastrointestinal leaks that can arise after surgery, in real-time.
- One Silicon Chip Photonics (OSCP) is developing the next generation of high-performance inertial measurement units, used to navigate a moving object or vehicle.
- Proof empowers governments to go paperless by streamlining internal approvals, digitizing application forms and improving policy decisions with data.
The four companies will join 20 other regional finalists at the Pitch@Palace Canada Final May 27-28 in Toronto, during Canadian Innovation Week.
BMO is the lead supporter of Pitch@Palace Canada and has been an outstanding partner throughout the On Tour series. “BMO wants to support people and entities who are creating value and jobs for their communities. Pitch@Palace Is an absolute perfect fit for BMO and we are happy to be here to support all of the creative ideas put forth by entrepreneurs across Canada,” said Filip Papich, Managing Director and Co-Head of BMO Capital Markets Quebec.
Thank you to all the entrepreneurs for applying and participating, to McGill University for being our regional partner and providing such a wonderful space, and to BMO for their continued support.
Only one question remains: Who will be selected to represent Canada across the Atlantic in London, UK? Stay tuned for updates and be sure to follow @RideauHallFdn on Twitter for the latest on Pitch@Palace Canada.